Navigation Links
NYU Cancer Institute experts present at American Society of Clinical Oncology annual meeting
Date:5/21/2010

study was completed in collaboration with two other institutions and research was supported by grants from the American Society of Hematology, St. Baldrick's Foundation, and the National Cancer Institute.


Abstract # 8596: Sunday, June 6th at 8:00 AM in Chicago, IL
Prognostic Relevance of Increased Detection of Lymphovascular Invasion in Primary Melanoma Using D2-40 and CD34 Compared to Routine Histology
Presenter: Farbod Darvishian, MD, assistant professor, Department of Pathology, NYU School of Medicine

Lymphovascular invasion (LVI) in melanoma is the identification of tumor cells within the lymphatic vessels. The presence of melanoma tumor cells inside these vessels has been shown to be associated with poorer patient prognosis. This negative prognostic marker for melanoma patients can sometimes be difficult to detect using routine histology techniques. However, use of immunohistochemical markers such as D2-40 or CD34 can increase the number of cases of LVI identified, but the prognostic relevance of this increased detection has not previously been assessed. In a study of 246 melanoma patients, researchers show that LVI detected using these immunohistochemical markers is a better predictor of outcome than LVI detected by histology alone. Results suggest that in melanoma cases when LVI is reported, the use of D2-40 or CD34 should be considered. Authors conclude, the use of these two special stains that highlight the vessels, help physicians better detect more cases of LVI than with the current histology techniques. The increased number of cases of LVI detected using these stains is clinically relevant, and thus if LVI is reported, pathologists should consider using these markers in addition to the current standard technique.


Abstract # 8553: Sunday, June 6th at 8:00 AM in Chicago, IL
The Use of Integrative Genomics to Define Molecular Signatures of Melanoma Histologic Subtypes
Presenter:
'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Gene fusions may be the smoking gun in prostate cancer development, U-M study finds
2. Study raises new concerns about radiation and breast cancer
3. Slight changes in 2 key genes appear to launch breast cancer development
4. TGen researcher awarded American Cancer Society fellowship
5. Einstein researcher awarded prestigious cancer research grant
6. Cancer: Trapping the escape artist
7. U-M study achieves reduced side effects in head and neck cancer treatment
8. Milk and risk of renal cell cancer: Genetic research sheds new light
9. Multistage nanovector system provides sustained delivery of siRNA cancer therapeutic in mice
10. Key mechanism identified in metastatic breast cancer
11. Flaxseed-fed chickens shed light on ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... 2015 ATL Technology, LLC, a top provider of ... single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Costa Rica ). This acquisition will incorporate ... with ATL Technology,s existing facility in Costa Rica ...
(Date:6/25/2015)... 25, 2015  Imagine a tool specifically designed to ... happier life. That,s exactly what USANA,s True Health ... cutting-edge, portable health program provides a personalized approached to ... improve your lifestyle and nutrition. At ... Wednesday night, USANA,s THA was honored with the Industry ...
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... of the best post-exercise recovery drinks could already be ... the American College of Sports Medicine conference this week. ... chocolate milk offered a recovery advantage to help repair ... drinks. Experts agree that the two-hour window ...
... called Bridget, was on display at the University today- ... staff and students with an exciting glimpse into the ... with celebrations marking the 50th anniversary of space research ... University of Leicester are involved in five instruments on ...
... gene that makes humans more susceptible to the potentially fatal ... virus affecting horses, according to scientists at the University ... the OAS1 gene has now been confirmed as increasing the ... a study led by Professor David Adelson (University ...
Cached Biology News:Chocolate milk is a 'natural' for post-exercise recovery 2Chocolate milk is a 'natural' for post-exercise recovery 3Life on Mars: University of Leicester to detect clues for alien existence 2Life on Mars: University of Leicester to detect clues for alien existence 3Mutant gene link to West Nile virus in horses 2
(Date:7/24/2015)... SHENYANG, China , July 24, 2015 ... and manufacturing platform , Expands product offering for ... addresses unmet medical needs in diabetes-related complications and dermatology ... 3SBio Inc., (HKEX:1530) ("3SBio" or ,the Company"), a ... on researching, developing, manufacturing and marketing biopharmaceutical products, today ...
(Date:7/23/2015)... ... 23, 2015 , ... The health and wellness of brain tumor caregivers, often ... brain tumor diagnosis. The American Brain Tumor Association presents interactive sessions that address shifting ... Conference, July 24-25 in Chicago. , “We have understood for a long-time now ...
(Date:7/23/2015)... KONG , July 23, 2015 The ... has been given the prestigious accolade of "Most ... for its world-class position in fostering innovation and ... Asia-Pacific region.  The ... a UK-based innovation and technology magazine and website ...
(Date:7/23/2015)... 23, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), are pleased to ... Drug (IND) Application with the U.S. Food and ... BHV-0223. Portage holds 54% equity interest in Biohaven, ... glutamate modulating agent and Biohaven has entered into ...
Breaking Biology Technology:3SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 2Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 3HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 2HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4
... Healthcare institutions often struggle with the numerous and ... expensive fines, and prevent an adverse Joint Commission ... (EH&E) has designed an automated management solution for ... Compliance Calendar is a customized, web-based management resource ...
... PITTSBURGH, March 17 Cardiorobotics, Inc., ... for use in a wide range of applications, ... the appointment of Dr. Samuel Straface in the ... excited that Dr. Straface has joined Cardiorobotics in ...
... 17 Oppenheimer & Co. Inc., a unit of Oppenheimer ... recent senior hires in the Investment Banking Department. Brian ... our Healthcare Investment Banking Group. Brian has more than 20 ... Co-head of Global Healthcare at JPMorgan. Prior to JPM, ...
Cached Biology Technology:Healthcare Institutions Can Now Stay Confidently Up-to-Date With New Regulatory Compliance Calendar 2Healthcare Institutions Can Now Stay Confidently Up-to-Date With New Regulatory Compliance Calendar 3Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company 2Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company 3Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking 2Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking 3